Product information

Current status:

Approved

Current status date:

2019-01-09

Product name:

TARO-DAPSONE

DIN:

02484625 Electronic product monograph is not available

Company:

TARO PHARMACEUTICALS INC
130 East Drive
Brampton
Ontario
Canada L6T 1C1

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

08:16.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

J04BA02 DAPSONE

Active ingredient group (AIG) number:^{See footnote5}

0106115001